Triple-receptor profile
Retatrutide, also referred to as LY3437943 in research literature, is a synthetic peptide with agonist activity at the GLP-1, GIP and glucagon receptors. This combination makes the molecule relevant to fundamental research into multireceptor signalling.
Molecular comparison
The VLT Labs catalogue offers 10 mg and 20 mg presentations. Within a controlled research environment, Retatrutide can be included in comparative ligand, receptor-binding and signal-transduction studies.
Scientific mechanism
Retatrutide, also referred to as LY3437943 in research literature, is a synthetic peptide with agonist activity at the GLP-1, GIP and glucagon receptors. In research models, these receptor interactions can be investigated through receptor binding and cAMP signalling, among other methods.
Batch documentation
Before each study, always check the product label, selected presentation and batch number. Compare these details, where available, with the batch documentation and lab results.
Important research-use notice
This item is intended exclusively for controlled analytical and in-vitro laboratory research. It is not intended for human or animal consumption, use, administration, diagnosis, prevention or treatment. VLT Labs does not provide dosage, medical, health or application advice.
